Ocular therapeutix, inc. (OCUL)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue, net

4,227

1,990

1,923

-

-

-

-

-

Total revenue

-

-

-

1,887

-

-

-

-

Product revenue

-

-

-

-

1,354

460

-

10

Collaboration revenue

-

-

-

-

396

312

-

-

Total revenue

-

-

-

-

1,750

772

-

10

Costs and operating expenses:
Cost of product revenue

2,325

465

457

-

-

-

-

-

Cost of product revenue

-

-

-

-

319

91

-

7

Research and development

41,091

36,915

30,880

27,065

26,611

18,880

10,517

11,540

Selling and marketing

24,491

4,942

17,000

6,701

3,852

1,982

625

657

General and administrative

22,122

18,786

15,509

11,004

9,165

6,913

1,761

1,477

Total costs and operating expenses

90,029

61,108

63,846

45,213

39,947

27,866

-

-

Total costs and operating expenses

-

-

-

-

-

-

12,903

13,681

Loss from operations

-85,802

-59,118

-61,923

-43,326

-38,197

-27,094

-12,903

-13,671

Other income (expense):
Interest income

1,229

879

424

304

166

7

13

4

Interest expense

6,101

1,739

1,892

1,680

1,724

1,119

441

377

Change in fair value of derivative liability

4,310

-

-

-

-

-

-

-

Other income (expense), net

-8

-

5

-1

7

-442

14

-49

Total other income (expense), net

-570

-860

-1,463

-1,377

-1,551

-1,554

-414

-422

Net loss and comprehensive loss

-86,372

-59,978

-63,386

-44,703

-39,748

-28,648

-13,317

-14,093

Accretion of redeemable convertible preferred stock to redemption value

-

-

-

-

-

11

27

35

Net loss attributable to common stockholders

-

-

-

-

-

-28,659

-13,344

-14,128

Net loss per share, basic and diluted

-1.91

-1.57

-2.20

-1.80

-1.71

-2.69

-5.11

-5.60

Weighted average common shares outstanding, basic and diluted

45,273

38,115

28,818

24,816

23,244

10,652

2,609

2,522

Comprehensive loss:
Net loss

-86,372

-59,978

-63,386

-44,703

-39,748

-28,648

-13,317

-14,093

Other comprehensive loss:
Unrealized gain on marketable securities

-

-

5

63

-68

-

-

-

Total other comprehensive income

-

-

5

63

-68

-

-

-

Total comprehensive loss

-86,372

-59,978

-63,381

-44,640

-39,816

-28,648

-13,317

-

Product
Total revenue

-

-

-

1,845

-

-

-

-

Cost of product revenue

-

-

-

443

-

-

-

-

Collaboration revenue
Total revenue

-

-

-

42

-

-

-

-